Cover Image
Market Research Report

Viral Vector Manufacturing

Published by Global Industry Analysts, Inc. Product code 909459
Published Content info 146 Pages
Delivery time: 1-2 business days
Price
Back to Top
Viral Vector Manufacturing
Published: May 1, 2020 Content info: 146 Pages
Description

Amid the COVID-19 crisis and the looming economic recession, the Viral Vector Manufacturing market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 23.2%. Retroviral Vectors, one of the segments analyzed and sized in this study, is forecast to grow at over 20.5% and reach a market size of US$412.1 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Retroviral Vectors market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 21.9% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$35.1 Million to the region's size over the next 7 to 8 years. In addition, over US$44.7 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Retroviral Vectors segment will reach a market size of US$25.7 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Viral Vector Manufacturing market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 19.7% over the next couple of years and add approximately US$120.6 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Viral Vector Manufacturing market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Cell and Gene Therapy Catapult; Cobra Biologics; FujiFilm Diosynth Biotechnologies U.S.A., Inc.; Lonza Group AG; Merck KgaA; Oxford Biomedica plc; Spark Therapeutics, Inc.; uniQure NV

Table of Contents
Product Code: MCP15508

TABLE OF CONTENTS

  • I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Viral Vector Manufacturing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Viral Vector Manufacturing Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
  • TABLE 2: Viral Vector Manufacturing Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
  • TABLE 3: Retroviral Vectors (Type) World Market by Region/Country in US$ Thousand:
  • 2020 to 2027
  • TABLE 4: Retroviral Vectors (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
  • TABLE 5: Adenoviral Vectors (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 6: Adenoviral Vectors (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
  • TABLE 7: Adeno-associated Viral Vectors (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
  • TABLE 8: Adeno-associated Viral Vectors (Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
  • TABLE 9: Other Viral Vectors (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
  • TABLE 10: Other Viral Vectors (Type) Market Share Breakdown by Region/Country:
  • 2020 VS 2027
    • TABLE 11: Pharmaceutical and Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
    • TABLE 12: Pharmaceutical and Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
    • TABLE 13: Research Institutes (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
    • TABLE 14: Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Viral Vector Manufacturing Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 15: United States Viral Vector Manufacturing Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
    • TABLE 16: United States Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 17: United States Viral Vector Manufacturing Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 18: Viral Vector Manufacturing Market Share Breakdown in the United States by End-Use: 2020 VS 2027
  • CANADA
    • TABLE 19: Canadian Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 20: Viral Vector Manufacturing Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 21: Canadian Viral Vector Manufacturing Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 22: Canadian Viral Vector Manufacturing Market Share Analysis by End-Use:
  • 2020 VS 2027
  • JAPAN
    • TABLE 23: Japanese Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 24: Japanese Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 25: Japanese Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 26: Viral Vector Manufacturing Market Share Shift in Japan by End-Use:
  • 2020 VS 2027
  • CHINA
    • TABLE 27: Chinese Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 28: Chinese Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 29: Chinese Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 30: Chinese Viral Vector Manufacturing Market Share Breakdown by End-Use: 2020 VS 2027
  • EUROPE
    • Market Facts & Figures
    • European Viral Vector Manufacturing Market: Competitor Market Share Scenario (in %)
    • or 2019 & 2025
    • Market Analytics
    • TABLE 31: European Viral Vector Manufacturing Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 32: European Viral Vector Manufacturing Market Share Shift by Region/Country: 2020 VS 2027
    • TABLE 33: European Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 34: European Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 35: European Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 36: European Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
  • FRANCE
    • TABLE 37: Viral Vector Manufacturing Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 38: French Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 39: Viral Vector Manufacturing Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
    • TABLE 40: French Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • GERMANY
    • TABLE 41: Viral Vector Manufacturing Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
    • TABLE 42: German Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 43: Viral Vector Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
    • TABLE 44: Viral Vector Manufacturing Market Share Distribution in Germany by End-Use: 2020 VS 2027
  • ITALY
    • TABLE 45: Italian Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
    • TABLE 46: Italian Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
    • TABLE 47: Italian Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 48: Italian Viral Vector Manufacturing Market Share Breakdown by End-Use:
  • 2020 VS 2027
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
    • TABLE 50: United Kingdom Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
    • TABLE 51: United Kingdom Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 52: Viral Vector Manufacturing Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
    • TABLE 54: Rest of Europe Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
    • TABLE 55: Rest of Europe Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
    • TABLE 56: Rest of Europe Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
  • ASIA-PACIFIC
    • TABLE 57: Viral Vector Manufacturing Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
    • TABLE 58: Asia-Pacific Viral Vector Manufacturing Market Share Analysis by Type:
  • 2020 VS 2027
    • TABLE 59: Viral Vector Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
    • TABLE 60: Asia-Pacific Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
  • REST OF WORLD
    • TABLE 61: Rest of World Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
    • TABLE 62: Viral Vector Manufacturing Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
    • TABLE 63: Rest of World Viral Vector Manufacturing Market Quantitative Demand Analysis
    • in US$ Thousand by End-Use: 2020 to 2027
    • TABLE 64: Rest of World Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION

  • Total Companies Profiled: 46
Back to Top